in groups 1 and 2 , ktz therapy reduced cholesterol ( 10 % , p less than or equal to .01 ; 19 % , p less than or equal to .05 ) and low-density lipoprotein ( ldl ) -cholesterol ( 13 % , p less than or equal to .05 ; 33 % , p less than or equal to .025 ) , and increased apolipoprotein ( apo ) a1 ( 7 % , p less than or equal to .005 ; 13 % , p less than or equal to .01 ) .
C0008377
cholesterol
C0023824
low-density lipoprotein